Reduction of striatal glucose metabolism in McLeod choreoacanthocytosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 4, 2001, Pages 517-520

  Oechsner, M ^a   Buchert, R ^a   Beyer, W ^a   Danek, A ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acanthocytosis; Chorea; McLeod syndrome; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ACANTHOCYTOSIS; ADULT; ARTICLE; BASAL GANGLION; CASE REPORT; CHOREA; CLINICAL EXAMINATION; CORPUS STRIATUM; FRONTAL LOBE; GLUCOSE METABOLISM; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYNDROME DELINEATION;

EID: 0035056963     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.4.517     Document Type: Article

References (22)

1. Marsh WL, Redman CM. The Kell blood group system: a review. Transfusion 1990;30:158-67.
2. Witt TN, Danek A, Reiter M, et al. McLeod syndrome: a distinct form of neuroacanthocytosis. J Neurol 1992;239: 302-6.
3. Ho M, Chelly J, Carter N, et al. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994;77:869-80.
4. Khamlichi S, Bailly P, Blanchard D, et al. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 1995;228:931-4.
5. Malandrini A, Fabrizi GM, Truschi F, et al. Atypical McLeod syndrome manifested as X-linked chorea-acanthocytosis, neuromyopathy and dilated cardiomyopathy: report of a family. J Neurol Sci 1994;124: 89-94.
6. Marsh WL, Redman CM. Recent developments in the Kell blood group system. Transfus Med Rev 1987;1:4-20.
7. Danek A, Uttner I, Vogl T, et al. Cerebral involvement in McLeod syndrome. Neurology 1994;44:117-20.
8. Swash M, Schwartz MS, Carter ND, et al. Benign X linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X linked muscular dystrophy. Brain 1983;106: 717-33.
9. Allen FH jr, Krabbe SMR, Corcoran PA. A new phenotype (McLeod) in the Kell blood group system. Vox Sang 1961; 6:555-60.
10. Schwartz SA, Marsh WL, Symmans A, et al. New clinical features of McLeod syndrome. Transfusion 1982;22:404.
11. Hardie RJ, Pullon WH, Hardipg AE, et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 1991;114:13-19.
12. Andersson JLR, Thurfjell L. Implementation and validation of a fully automatic system for intra- and interindividual registration of PET brain scans. J Comput Assist Tomogr 1997;21:136-44.
13. Serra S, Xerra A, Scribano Emeduri M, et al. Computerized tomography in amyotrophic choreo-acanthocytosis. Neuroradiology 1987;29:480-2.
14. Alonso ME, Teixeira F, Jimenez G, et al. Chorea-acanthocytosis: report of a family and neuropathological study of two cases. Can J Neurol Sci 1989;16:426-31.
15. Dubinsky RM, Hallett M, Levey R, et al. Regional brain glucose metabolism in neuroacanthocytosis. Neurology 1989;39:1253-5.
16. Hosokawa S, Ichiya Y, Kuwabara Y, et al. Positron emission tomography in cases of chorea with different underlying diseases. J Neurol Neurosurg Psychiatry 1987;50:1284-7.
17. 18F-Dopa uptake by PET in cases of chorea with or without dementia. J Neurol Sci 1993;115: 153-7.
18. Delecluse F, Deleval J, Gerard JM, et al. Frontal impairment and hypoperfusion in neuroacanthocytosis. Arch Neurol 1991;48:232-4.
19. Brooks DJ, Ibanez V, Playford ED, et al. Presynaptic and postsynaptic striatal dopaminergic function in neuroacanthocytosis: a positron emission tomographic study. Ann Neurol 1991;30:166-71.
20. Medalia A, Merriam A, Sandberg M. Neuropsychological deficits in choreoacanthocytosis. Arch Neurol 1989;46:573-5.
21. Kuwert T, Lange HW, Boecker H, et al. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease. J Neurol 1993;241:31-6.
22. Martin WRW, Clark C, Ammann W, et al. Cortical glucose metabolism in Huntington's disease. Neurology 1992;42: 223-9.